APA (7th ed.) Citation

G, M., N, T., JJ, R., F, M., I, G., H, Y., . . . S, C. (2024). Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia. Cell reports. Medicine, 5(6), 101585. https://doi.org/10.1016/j.xcrm.2024.101585

Chicago Style (17th ed.) Citation

G, Montalban-Bravo, et al. "Targeting MCL1-driven Anti-apoptotic Pathways Overcomes Blast Progression After Hypomethylating Agent Failure in Chronic Myelomonocytic Leukemia." Cell Reports. Medicine 5, no. 6 (2024): 101585. https://doi.org/10.1016/j.xcrm.2024.101585.

MLA (9th ed.) Citation

G, Montalban-Bravo, et al. "Targeting MCL1-driven Anti-apoptotic Pathways Overcomes Blast Progression After Hypomethylating Agent Failure in Chronic Myelomonocytic Leukemia." Cell Reports. Medicine, vol. 5, no. 6, 2024, p. 101585, https://doi.org/10.1016/j.xcrm.2024.101585.